Company Overview and News

21
Believe It Or Not: This Highest-Rated Qualified Dividend Preferred Stock Is One Of The Highest Yielders

2018-10-13 seekingalpha
KKR has converted to a corporate structure and now pays a qualified dividend and for tax purposes now issues a 1099 rather than a K-1.
BGX C NTRSP CG BGLF BX APO BGB PRE MS

1
KKR plays both sides on Sedgwick Claims buyout

2018-10-12 reuters
NEW YORK, Oct 12 (LPC) - KKR Capital Markets is arranging a leveraged financing that will back the US$6.7bn sale of one of its portfolio companies, insurance services provider Sedgwick, as private equity firms continue to boost their lending capabilities.
CG MS

33
EU mergers and takeovers (Oct 12)

2018-10-12 reuters
BRUSSELS, Oct 12 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 LBTY HGKGF DTEGF WHR 500470 LBTYK LILAB DIS DLELY AVOL FOX SPR LBTYB LBTYA HGKGY IDL CG SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

33
UPDATE 1-EU mergers and takeovers (Oct 11)

2018-10-11 reuters
BRUSSELS, Oct 11 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 LBTY HGKGF DTEGF WHR 500470 LBTYK LILAB DIS DLELY AVOL FOX SPR LBTYB LBTYA HGKGY IDL CG SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

1
NioCorp and Traxys North America Agree to Commercial Sales Contract for up to 120 Tonnes of Scandium Over 10 Years

2018-10-10 globenewswire
CENTENNIAL, Colo., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NioCorp Developments Ltd. (“NioCorp” or the “Company”) (TSX: NB; OTCQX: NIOBF; and FSE: BR3) is pleased to announce that it has signed a commercial sales agreement with Traxys North America LLC (“Traxys”) for up to 120 tonnes of scandium trioxide over the first 10 years of operation of NioCorp’s planned Elk Creek Critical Minerals Project (the “Project”) in Nebraska.
NIOBF NB CG

33
UPDATE 1-EU mergers and takeovers (Oct 10)

2018-10-10 reuters
BRUSSELS, Oct 10 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 LBTY HGKGF DTEGF WHR 500470 LBTYK LILAB DIS DLELY AVOL FOX SPR LBTYB LBTYA HGKGY IDL CG SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

15
Deals Buzz: IDG Ventures plans to raise $300 million under new brand name

2018-10-10 livemint
Mint brings you your dose of the top deals news, reported from newsrooms across the country
BGX 532617 JETAIRWAYS CG BGLF BX SFTBF BGB PNJZY 532461 PNB 9984 SFTBY

1
Former Akzo Nobel chemicals back to market in 3-5 years - CEO

2018-10-09 reuters
AMSTERDAM (Reuters) - Akzo Nobel’s former chemicals subsidiary will likely return to the market as a standalone public company in three to five years, its new CEO Charles Shaver said on Tuesday.
AKZA CG

9
Arconic Stock Gets a Boost From Bid Buzz

2018-10-09 investorplace
Arconic stock (NYSE:ARNC) was on the up and up on Monday as the company is being targeted for a buyout by a large private-equity consortium.
CG ARNC

24
Large private equity consortium forms for Arconic bid

2018-10-09 thestar.com.my
NEW YORK: Blackstone Group LP, Carlyle Group LP, Onex Corp and Canada Pension Plan Investment Board have joined forces in a bid to acquire aluminum products maker Arconic Inc, according to sources.
BGX CG BGLF BX ARNC APO BGB AAI TRI AA

32
EU mergers and takeovers (Oct 8)

2018-10-08 reuters
BRUSSELS, Oct 8 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 LBTY HGKGF DTEGF 500470 LBTYK LILAB DIS DLELY AVOL FOX SPR LBTYB LBTYA HGKGY IDL CG SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

9
TD Ameritrade Invests in Regulated Crypto Exchange Platform

2018-10-05 zacks
TD Ameritrade Holding Corporation (AMTD - Free Report) is investing in a regulated derivatives exchange and clearing organization — ErisX, with an aim to make digital currency products more accessible to retail clients. Financial terms of the deal were not disclosed.
ETFC VIRT AMTD CG PBB PSEC YY

13
An 8% Yield, With Record Earnings, No K-1, And Rising Rate Protection

2018-10-05 seekingalpha - 2
In mid-September, Seaspan Corp. (SSW), the world's largest independent owner, operator and manager of containerships, issued a new preferred series, Seaspan Corp., 8.00% Series I Fixed/Float Cumulative Redeemable Perpetual Preferred Shares, (SSW.PI).
FXFLF SSW FXFHF FAXXF CG FRFHF SSWN FRFGF FRFFF FRFZF FAXRF FRFXF BGK SSWA

28
EU mergers and takeovers (Oct 5)

2018-10-05 reuters
BRUSSELS, Oct 5 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 FOX HGKGF SPR HGKGY IDL CG SNEJF DTEGF BKNG 500470 TTST TATASTEEL TATLY SNE MSFT HPQ FOXA DTEGY DIS DLELY AVOL

3
Is Carlyle Group (CG) Stock Undervalued Right Now?

2018-10-04 zacks
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
CSBR CG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CG / The Carlyle Group L.P. on message board site Silicon Investor.

CNCG...can the CNCG...can the CNCG...can the CGI Group (GIB.A) - CGI Group (GIB.A) - CGI Group (GIB.A) -
Cgw-Wireless Company Cgw-Wireless Company Cgw-Wireless Company CardioCom .com(Ccg-Cdnx CardioCom .com(Ccg-Cdnx CardioCom .com(Ccg-Cdnx
Internet Capital Group Inc. (ICGE) Internet Capital Group Inc. (ICGE) Internet Capital Group Inc. (ICGE) Anglo Canadian Oil (ACG.V) Anglo Canadian Oil (ACG.V) Anglo Canadian Oil (ACG.V)
WTCG WTCG WTCG Ken Heebner and CGM Focus Fund CGMFX Ken Heebner and CGM Focus Fund CGMFX Ken Heebner and CGM Focus Fund CGMFX
Envit Capital Group, Inc. (ECGP) - A Publicly Traded Hedge F Envit Capital Group, Inc. (ECGP) - A Publicly Traded Hedge F Envit Capital Group, Inc. (ECGP) - A Publicly Traded Hedge F Lighting Science Group Corporation (OTC Bulletin Board: LSCG Lighting Science Group Corporation (OTC Bulletin Board: LSCG Lighting Science Group Corporation (OTC Bulletin Board: LSCG
CUSIP: 14309L102